Evaluation of the Housing First program in patients with severe mental disorders in France: study protocol for a randomized controlled trial. by Tinland, Aurelie et al.
Evaluation of the Housing First program in patients
with severe mental disorders in France: study protocol
for a randomized controlled trial.
Aurelie Tinland, Cecile Fortanier, Vincent Girard, Christian Laval, Benjamin
Videau, Pauline Rhenter, Tim Greacen, Bruno Falissard, The´mis Apostolidis,
Christophe Lanc¸on, et al.
To cite this version:
Aurelie Tinland, Cecile Fortanier, Vincent Girard, Christian Laval, Benjamin Videau, et al..
Evaluation of the Housing First program in patients with severe mental disorders in France:
study protocol for a randomized controlled trial.. Trials, BioMed Central, 2013, 14 (1), pp.309.
<10.1186/1745-6215-14-309>. <inserm-00870183>
HAL Id: inserm-00870183
http://www.hal.inserm.fr/inserm-00870183
Submitted on 6 Oct 2013
HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.
L’archive ouverte pluridisciplinaire HAL, est
destine´e au de´poˆt et a` la diffusion de documents
scientifiques de niveau recherche, publie´s ou non,
e´manant des e´tablissements d’enseignement et de
recherche franc¸ais ou e´trangers, des laboratoires
publics ou prive´s.
TRIALS
Tinland et al. Trials 2013, 14:309
http://www.trialsjournal.com/content/14/1/309STUDY PROTOCOL Open AccessEvaluation of the Housing First program in
patients with severe mental disorders in France:
study protocol for a randomized controlled trial
Aurelie Tinland1,2, Cecile Fortanier1,6, Vincent Girard1,2, Christian Laval1, Benjamin Videau1, Pauline Rhenter1,
Tim Greacen3, Bruno Falissard4, Themis Apostolidis5, Christophe Lançon1,2, Laurent Boyer1 and Pascal Auquier1*Abstract
Background: Recent studies in North American contexts have suggested that the Housing First model is a
promising strategy for providing effective services to homeless people with mental illness. In the context of the
highly generous French national health and social care system, which is easily accessible and does not require out-
of-pocket payment, the French Health Ministry insists on rigorous techniques, including randomized protocols, to
evaluate the impact of Housing First approaches in France.
Method and design: A prospective randomized trial was designed to assess the impact of a Housing First
intervention on health outcomes and costs over a period of 24 months on homeless people with severe mental
illness, compared to Treatment-As-Usual. The study is being conducted in four cities in France: Lille, Marseille, Paris
and Toulouse. The inclusion criteria are as follows: over 18 years of age, absolutely homeless or in precarious
housing, and possessing a ‘high’ level of need: diagnosis of schizophrenia or bipolar disorder and moderate to
severe disability according to the Multnomah Community Ability Scale (score ≤ 62) and at least one of the
following three criteria: 1) having been hospitalized for mental illness two or more times in any one year during the
preceding five years; 2) co-morbid alcohol or substance use; and 3) having been recently arrested or incarcerated.
Participants will be randomized to receiving the Housing First intervention or Treatment-As-Usual. The Housing First
intervention provides immediate access to independent housing and community care. The primary outcome
criterion is the use of high-cost health services (that is,, number of hospital admissions and number of emergency
department visits) during the 24-month follow-up period. Secondary outcome measures include health outcomes,
social functioning, housing stability and contact with police services. An evaluation of the cost-effectiveness and
cost-utility of Housing First will also be conducted. A total of 300 individuals per group will be included.
Discussion: This is the first study to examine the impact of a Housing First intervention compared to Treatment-
As-Usual in France. It should provide key information to policymakers concerning the cost-effectiveness and health
outcomes of the Housing First model in the French context.
Trial registration: The current clinical trial number is NCT01570712
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Homelessness, defined as the absence of customary and
regular access to a conventional dwelling or residence
[1], has been recognized as a growing social and public
health problem in developed countries since the end of
the 1980s. An estimated 100,000 people live on the
streets in Francea. The number of homeless people is
expected to rise in the current economic context of
growing inequalities with potentially dramatic effects on
health [2,3]. Indeed, homeless people in most Western
countries have limited access to appropriate care for
their complex health care needs [4]. Adherence to treat-
ment and continuity of care are often poor [5]. They also
have a greater risk of engaging in health-damaging be-
haviors, including tobacco, alcohol and drug dependence
in particular [6,7]. In addition, it has been estimated that
more than one in four homeless people suffer from ser-
ious mental illnesses, such as schizophrenia or bipolar
disorder [8-11]. Providing care to those homeless people
with severe mental illness is particularly challenging
[12]: they are more likely to remain homeless for longer
periods of time and to require more health support (that
is, they tend to be in poorer physical health and to have
more substance abuse co-morbidity) and more social
support (that is, they have less social support, they en-
counter more barriers to employment and they have
more contact with the legal system) than homeless
people who do not suffer from mental illness [13,14].
Over the last several decades, two main approaches
have been investigated regarding treatment for homeless
people with mental illness in the United States and
Canada [15,16]. The Treatment First model, also called
Continuum of Care, requires that homeless people first
address mental health issues and/or drug misuse, mov-
ing progressively up a ‘staircase of transition’ before fi-
nally accessing independent housing [17]. In contrast to
this model, which predominates in many European
countries, including France, the Housing First model re-
verses this sequence by offering immediate access to
stable housing [18]. Individuals can exercise some degree
of choice regarding the location and type of housing
they receive. No pre-conditions, such as being stabilized
on medications or bringing substance abuse under con-
trol, are necessary. In addition, homeless people in the
Housing First model access support from a multidiscip-
linary team, following a well-defined intensive case man-
agement (ICM) program for people with moderate needs
(that is, participant/staff ratio = 20:1; availability: five
days/week, eight hours/day) or assertive community
treatment (ACT) for those with greater needs (that is,
participant/staff ratio = 10:1; availability: seven days/
week, twenty-four hours/day).
Recent reviews of the literature suggest that in North
American contexts, the Housing First model is particularlyappropriate for homeless people with mental illness [15,16].
Compared to Treatment First or Treatment-As-Usual pro-
grams, Housing First programs report greater residential
stability and fewer arrests, greater control over drug and al-
cohol use, better health outcomes and well-being, and
lower residential and health costs [18-24]. However, is the
Housing First model applicable in European contexts [25]?
To our knowledge, no randomized studies have explored
the impact of the Housing First model in Europe. Given
the important differences in health and social care
provision [26,27], such models need to be tested and evalu-
ated in these highly generous care contexts, such as in
France, before implementation on a larger scale. In line
with international recommendations on poverty policies
and programs [28,29] and a recent French national report
on health and homelessness [30], the French Ministry of
Health recommends applying rigorous techniques, such as
randomized evaluations, to develop and test the Housing
First model with real-world problems faced by the home-
less in France. We thus designed a prospective randomized
trial to assess the impact of a Housing First intervention in
comparison with Treatment-As-Usual (that is,, control
group receiving existing supports and services in each site)
on health outcomes and costs for homeless people with se-
vere mental illness. This project is supported both by pri-
vate (less than 10%) funding sources and public funding
sources, issued from different policymakers in charge of
medical, social, housing and research services.
Methods and design
Study objectives
The primary objective is to assess the impact of a Hous-
ing First intervention in comparison with Treatment-As-
Usual on the use of high-cost health services (that is,
number of hospital admissions and number of emer-
gency department visits) over a 24-month period by
homeless people with severe mental illness in France.
The secondary objectives are: (1) to assess the impact
of the Housing First intervention on the number of days
in hospital and health outcomes (that is, mental health,
physical health, alcohol and substance use, quality of life
and recovery), adherence to medication, social function-
ing, housing stability and contact with legal services;
(2) to measure the cost effectiveness and cost utility
of the Housing First intervention in comparison with
Treatment-As-Usual; and (3) to describe changes in pro-
fessional culture and practices of the different stake-
holders involved in the Housing First program, including
policymakers, professionals and users, using qualitative
research methods.
Study site and population
The study is being conducted in four major cities in
France: Lille, Marseille, Toulouse and the capital city,
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of age; absolutely homelessb or precariously housedc; li-
ving in the city in question for more than six months
and intending to stay in that same city for the coming
two years; possessing a ‘higher’ level of need, defined as
having a diagnosis of schizophrenia or bipolar disorder
according to Diagnostic and Statistical Manual of Mental
Disorders, fourth edition (DSM-IV-TR) criteria [31] and
moderate to severe disability according the Multnomah
Community Ability Scale (score ≤ 62) [32,33] and meet
at least one of the following three criteria: 1) having
been hospitalized for mental illness two or more times
in any one year over the last five years, or 2) having co-
morbid alcohol or substance use, or 3) having been
arrested or incarcerated over the last two years; being
covered by French government health insurance includ-
ing free state aid; and speaking French. Exclusion criteria
included the following: being considered unable to pro-
vide informed consent [34]; having dependent children;
pregnancy; or a DSM-IV Axis I diagnosis other than
schizophrenia or bipolar disorder.
Study design and procedure
The present study is a 24-month, prospective, random-
ized, controlled, open-label, and multi-site study, based
on a mixed approach combining quantitative and quali-
tative methods. Subjects are referred from a wide variety
of services including mobile outreach teams [35], com-
munity mental health services, general hospitals and ac-
cess to health care and public services teams (Figure 1).
Trained research assistants check eligibility criteria
within 24 hours of referral. The results from the Mini
International Neuropsychiatric Interview are given by a
psychiatrist [36]. The assistants describe the study, re-
spond to any questions the candidates may have and ob-
tain written informed consent. Participants are then
randomly assigned to either the Housing First interven-
tion (Group 1) or Treatment-As-Usual care (Group 2).
Randomization is stratified by site and a computer-
generated, randomized list is created using a permuted
block design. Quantitative data are collected during
face-to-face interviews by the trained research assistants
at five different points in time: at randomization (base-
line; T0) and then at 6 (T1), 12 (T2), 18 (T3) and
24 months (T4) after randomization. All data are col-
lected using netbook (small inexpensive laptop com-
puters) computer-assisted interviewing and transferred
to a highly secure central database without using inter-
net (EpiConcept®) http://www.epiconcept.fr/.
The qualitative approach is based on a generalizable
study design (that is, to determine whether the Housing
First model evaluated in this study may be transposed to
other real-life settings in the French context) [37] using
validated methods for assessing health care includingobservational data from participants, interviews and
focus groups [38,39]. The persons who carry out the re-
search will enter the culture of those they study and ex-
perience the events in the way in which the participants
experience them. In addition to direct observation, in-
depth interviews and focus groups with policymakers,
professionals and users will be performed. Interviews
and focus groups will be recorded and transcribed ver-
batim. These methods will be administered at (base-
line; T0) and then at 6 (T1), 12 (T2), 18 (T3) and
24 months (T4).
The assessment schedule is presented in Table 1.
Groups
• Group 1 (‘Housing First’): participants are provided
with immediate access to independent housing. How-
ever, they must agree to accept a maximum of 30% of
their income paid directly as rent and receive home
visits at least once a week by program staff. In addition,
they have access to a recovery-oriented, assertive com-
munity treatment (ACT) team [40] which includes a
doctor, a nurse, a social worker and a peer worker. In
particular, this team provides case management, mental
health services, employment and housing assistance,
substance abuse services and other services to allow the
individual to live successfully in the community.
• Group 2 (‘Treatment-As-Usual’): homeless indivi-
duals receive usual care, that is, pre-existing programs
and services in the cities of Lille, Marseille, Paris and
Toulouse.
Evaluation criteria
Primary objective
The primary evaluation criterion is the use, during the
24-month follow-up period, of more costly health ser-
vices, as measured by the number of hospital admissions
and number of emergency department visits.
Secondary objectives
Mental health is specifically assessed using the Modified
Colorado Symptom Index (MCSI) [41] and the Clinical
Global Impression (CGI) [42]. The MCSI contains 14
items which evaluate how often in the past month an in-
dividual has experienced a variety of mental health
symptoms, including loneliness, depression, anxiety, and
paranoia. Higher scores indicate a greater likelihood of
mental health problems. The CGI rates the overall seve-
rity of any mental disorder, on a scale of the overall
current severity of symptoms from 1 (healthy, not ill) to
7 (severely ill). The CGI is sensitive to change and corre-
lates well with changes assessed with more complex
scales [43,44].
Alcohol and substance use is assessed using sections
K and L of the Mini International Neuropsychiatric
Referents
Mobile outreach teams
Access to health care and public service teams (PASS)
Emergency departments and hospitals (somatic and psychiatric care)
Assessment of homeless for eligibility by clinical research assistants 
and psychiatrists
Age > 18 years
Absolutely homeless or precarious housing
High level of need, including diagnosis of schizoph renia or bipolar 
disorder
Randomisation of 
homeless individuals
Housing First with 
assertive community 
treatment (N =300)
Treatment as usual* 
(N=300)
Follow-up evaluation at baseline, 6, 12, 18 and 24 months 
by clinical research assistants
Figure 1 Flowchart of the study protocol.
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structured diagnostic interview that determines the
presence or absence of diagnoses of dependence on
and/or abuse of alcohol and/or the more frequently
used or more problematic drugs, and whether the
diagnosis is current (preceding 12 months) and/or a
lifetime diagnosis (anytime in life - may or may not
be current).
Adherence is assessed with the Medication Adherence
Rating Scale (MARS) [45], a 10-item, multidimensional,
self-reporting instrument describing three dimensions:
‘medication adherence behavior’, ‘attitude toward taking
medication’ and ‘negative side-effects and attitudes to psy-
chotropic medication’. A high score correlates with a
higher likelihood of medication adherence.Global physical and mental health status is assessed
using the 36-item Short Form Health Survey (SF-36) of
the Medical Outcomes Study [46]. The SF-36 is a self-
administered questionnaire consisting of 36 items de-
scribing eight dimensions: physical functioning, social
functioning, role-physical problems, role-emotional
problems, mental health, vitality, bodily pain, and gen-
eral health. Two composite scores can be calculated: the
physical composite score and the mental composite
score. Each dimension is scored within a range from 0
(poor health status) to 100 (good health status).
Quality of life is assessed using the S-QoL 18 [47],
which is a self-administered, multidimensional question-
naire developed and validated for the specific assessment
of quality of life in patients with mental disorders
Table 1 Assessment schedule
Screening Evaluation
Baseline 6 months 12 months 18 months 24 months
Eligibility criteria x
Informed consent x
Health care use x X x x
MCSI x x x x x
CGI x x x x x
MINI x x x x x
MARS x x x x x
SF-36 x x x x x
S-QoL 18 x x x x x
EuroQoL 5D x x x x x
RAS x x x x x
MCAS x x x x x x
Ad hoc questionnaires x x x x x
Cost analysis x x x x
CGI, clinical global impression; Health care use, number of admissions to hospital, total days in hospital and number of emergency department visits; MARS,
medication adherence rating scale (MARS); MCAS, Multnomah community integration scale MINI, mini international neuropsychiatric interview, sections K and L;
MCSI, modified Colorado symptom index; RAS, recovery assessment scale; SF-36, medical outcomes study 36-item short form health survey; S-QoL 18,
schizophrenia quality of life questionnaire.
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eight dimensions: psychological well-being, self-esteem,
family relationships, relationships with friends, resili-
ence, physical well-being, autonomy, and sentimental
life. It also generates a global score. Dimension and
index scores range from 0, indicating the lowest quality
of life, to 100, the highest quality of life.
Health status is assessed using the EuroQoL 5D [49], a
standardized instrument for use as a measure of health
outcomes, providing a simple descriptive profile and a sin-
gle index value. This self-administered questionnaire mea-
sures five dimensions: mobility, personal care, routine
occupations, pain and discomfort, and anxiety and depres-
sion. Each dimension has three levels: no problems, some
problems, and severe problems.
Recovery is assessed using the Recovery Assessment
Scale (RAS) [50], which measures various aspects of re-
covery from the perspective of the consumer, with a par-
ticular emphasis on hope and self-determination. This
self-administered instrument comprises 24 items, ex-
ploring five domains: personal confidence and hope,
willingness to ask for help, goal and success orientation,
reliance on others, and no domination by symptoms. A
higher score indicates better recovery.
Social functioning is assessed using the Multnomah
Community Integration Scale (MCAS) [32,33]. The
MCAS is a 17-item instrument that measures the degree
of functional ability of adult clients who have severe and
persistent mental disorders and who live in the
community. Items are grouped into four categories: 1)interference with functioning; 2) adjustment to living; 3)
social skills; and 4) behavioral problems. Higher scores
indicate more severe disability.
The following parameters are also recorded by re-
search assistants using ad hoc questionnaires elaborated
by the steering committee composed of economists,
psychiatrists, psychologists, social workers and sociolo-
gists: gender, age, education level, social minimums and
administrative situation, employment status, social net-
work, health events, housing stability, contact with legal
services, use of social services (for example., emergency
shelters, transition shelters, stabilization shelters, suppor-
tive housing, and hostels) and experience of violence.
In the cost analysis, direct and indirect costs are mea-
sured during the 24-month follow-up period. Direct costs
comprise the costs related to medical/health, legal, hous-
ing, and social services (that is, hospital days; emergency
department visits; outpatient visits; use of substance abuse
treatment centers; legal services, including days detained
in jails and prisons; days in respite, shelter, and other
housing; and case management) and indirect costs mainly
related to loss of productivity [51,52]. Data are collected
using national administrative, social and medical data-
bases; medical records; structured interviews with research
participants and the standardized Short Form-Health and
Labor questionnaire (SF-H&L) [53]. The SF-H&L inquires
about productivity losses that are caused by health prob-
lems in general: absenteeism from paid work, production
losses without absenteeism from paid work and hindrance
in the performance of paid and unpaid work.
Tinland et al. Trials 2013, 14:309 Page 6 of 10
http://www.trialsjournal.com/content/14/1/309Sample size
Sample size was calculated to obtain 90% power, to de-
tect a 20% difference in the use of costly health care ser-
vices (reference points = 3.6 for the number of
hospitalizations and 5.7 for the number of emergency
department visits [54]) at 24 months between the two
groups. With a significant P-value of 0.05, these calcula-
tions showed that a total of 250 individuals per group
was required; allowing for a potential 20% of patients be-
ing lost to follow-up, a total of 600 will need to be in-
cluded, that is, 150 at each site.
In the qualitative study, an extensive review of relevant
literature and theory will guide sample selection from
the four sites to capture diversity of experiences in the
Housing First program. Adjustment will be performed in
the course of the study to respond to unanticipated pat-
terns of subgroups of experiences, which may need in-
creased representation in the sample.
Strategies for reducing attrition
Several strategies are used to minimize loss to follow-up.
First, the study has been designed so that research assis-
tants can spend a large amount of time tracking partici-
pants. Research assistants will receive specific training
by existing mental health outreach teams to establish
quality working alliances with homeless individuals. At
baseline, research assistants underline the importance of
participating in the follow-up interviews. Participants are
asked to provide information about their families,
friends, habits, service providers, and so forth that could
help locate them. In addition, participants of the control
group will receive €21 worth of food coupons for each
interview.
Statistical analysis
The data will be summarized using the mean, median,
standard deviation and range for quantitative data and
counts and frequencies for categorical data. The analyses
on the primary and secondary criteria will be performed
on the intent-to-treat population (that is, comparison of
patients in the group to which they were originally ran-
domly assigned). We will conduct analyses for each of
the outcomes separately (that is, number of hospital ad-
missions and number of emergency department visits).
In addition, complementary per protocol analyses will be
performed (that is, comparison of patients who com-
pleted the treatment originally allocated). Finally, miss-
ing data will be handled where possible (for example,
quality of life and recovery) using multiple imputations;
sensitivity analysis will be conducted.
Comparisons between the two groups for each out-
come will be performed using Student’s t-tests or
Mann–Whitney-Wilcoxon tests for quantitative or or-
dinal variables, and chi-square or Fisher’s exact tests forfrequencies. Non-parametric tests will be used for data
that is not normally distributed. Multivariate analyses
will be performed primarily using negative binomial re-
gression models for the number of admissions to hos-
pital and a gamma distribution for the number of days
in hospital, adjusting for the length of follow-up. Mul-
tiple imputation techniques for missing data will be
discussed. Moreover, linear regression models will be
used. The dependent variable will be the primary evalu-
ation criterion (that is, the use of the health care sys-
tem). Explanatory variables will be selected among those
for which the P-value is less than or equal to 0.20 in uni-
variate analysis, and described in the literature as being
associated with use of the health care system. The par-
ameter ‘site’ will be considered as a confounding factor.
The results will be presented in the form of standardized
beta coefficients.
Statistical significance is defined as P < 0.05. Statistical
analyses will be performed using SPSS Statistics for
Windows, Version 17.0 ( SPSS Inc., Chicago, IL, USA).
Cost analysis
An economic evaluation will be carried out from a soci-
etal perspective and according to the French guidelines
for costing in economic evaluations [55,56].
Direct costs will be calculated by weighing the use of
health, legal, housing, and social services by unit cost
estimates obtained from French national data sets and
reports, for example, from the national database for out-
patient visits and Health Ministry hospital reimburse-
ment reports for inpatient care and day-clinic treatment.
Two methods of calculating indirect costs will be exa-
mined: the traditional human capital approach and the
developed friction cost method [57,58]. Benefits will be
assessed in terms of recovery (RAS) [59] and health sta-
tus (EuroQoL 5D). Efficiency will be evaluated using the
Incremental Cost-Effectiveness Ratio (ICER), defined as
cost per recovery point or QALY gained with ‘Housing
First’ versus ‘Treatment-As-Usual.’
Qualitative analysis
Analysis will be essentially based on a taxonomic
process. Content analysis of interviews and focus groups
will be performed by sociologists who are skilled in tex-
tual analysis, complemented by a computerized textual
analysis. Data will be sorted to give coherent categories
of experience, drawing not only on the initial theoretical
framework but also on theoretical concepts that emerge
from the data. Special attention will be given to the
evaluation of the institutional and political dynamics in-
volved in traditional rehabilitation approaches, the tra-
jectories and energies in interplay in the recovery-based
Housing First program, the relationship between citizen-
ship and processes of rehabilitation and recovery and,
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a larger scale should the results prove positive.Ethical principles and safety
The study is designed and carried out in accordance
with the principles of the Declaration of Helsinki, sixth
revision [60]. The patients are provided with both oral
and written information regarding the study prior to
obtaining their informed consent. The local ethics com-
mittee (Comité de Protection des Personnes Sud-M
éditerranée, France) approved this study, which is regis-
tered with the international standard randomized con-
trol trial number (NCT01570712).Discussion
This study is the first large-scale attempt to assess the
applicability of the Housing First model on homeless
people with serious mental illness in France. Several
studies have provided evidence regarding the effective-
ness of the Housing First model in North American con-
texts [15,16,21,23,54,61]. However, the extent to which
the Housing First model could be replicated in France
needs to be rigorously investigated [30]. The manage-
ment of health care and housing for homeless people
with mental disorders in France is significantly different
from health and social care services in the North Ameri-
can contexts where the aforementioned studies were car-
ried out. Generalization from the findings and expected
benefits of these studies of North American contexts to
the French context would be hazardous. Indeed, the
health care policy of universal coverage in France, as op-
posed to nonuniversal coverage, may have a significant
impact on the management of care for homeless people
with mental disorders [26]. A recent study has suggested
that access to care for homeless people may be higher in
France, with its near-universal coverage and free mental
health system [5]. In addition, mobile mental health out-
reach teams including doctors, nurses and social workers
have been created since 2005 to ensure the provision of
health, mental health and social care for ‘hard to reach’
homeless individuals with and without severe mental
disorders [35]. Finally, a range of social aid and housing
services can be easily accessed by all citizens in France
who meet appropriate criteria, including direct financial
support, disability allowances and housing assistance. Of
particular note is the 2007 legislation introducing a the-
oretically enforceable right to housing for all citizens.
Thus, services provided in the current study for the
Treatment-As-Usual group are far more extensive than
in previous studies in other national contexts. The
present study is therefore of great importance to confirm
whether these previous findings can be generalized to
the French-specific context.A major strength of the current project is the propos-
ition of a rigorous evaluation of two policy options
(‘Housing First’ versus ‘Treatment-As-Usual’) with re-
gard to answering the specific needs of the homeless in
France. Although randomized experiments have become
increasingly popular in recent years, medico-social ex-
periments in real-life contexts using a randomized pro-
ject design as in the current study are still relatively rare
[29]. The advantage of this approach is that the results
are more representative of everyday practices and pro-
vide significant evidence regarding the feasibility of using
the Housing First intervention as part of ongoing rou-
tine care management in the French context. This thus
increases the generalizability of the results and supports
implementation [62]. Another advantage of randomized
experiments is the interplay between theory and experi-
mental research resulting from the close collaboration
between researchers and implementers/policymakers
[63]. In the present study, special attention has been
paid to this sort of collaboration, involving a large num-
ber of professionals working closely together, including
policymakers at national and local levels; researchers
from multiple domains, including psychiatrists, public
health professionals, sociologists and economists work-
ing within an independent national scientific committee
(Institut de Recherche en Santé Publique); and health
and social care professionals (doctors, nurses, social
workers and peer workers). Finally, this study has been
granted a significant budget, drawn from public funds
with large teams of professionals, enabling the implemen-
tation of this complex intervention. Ambitious experi-
ments as in the present study are all the more likely to
be useful for influencing national policy in these areas [64].
Another strength and originality of the present study
is the proposition of a qualitative approach in addition
to quantitative methods to investigate the complex
health and social issues surrounding the current Hous-
ing First program. Qualitative research is particularly
well suited to understanding complex phenomena,
uncovering links among concept and behaviors, and
generating and refining theory applicable to specific con-
texts [65]. In addition, mixed methods approaches, in-
cluding qualitative and quantitative approaches, provide
unique contributions to outcomes research [65,66].
This study has several limitations. Even with the large
overall sample size in this multicenter study, the sample is
not representative of the homeless population as a whole.
The inclusion criteria used in the present study only con-
cern a particular section of the homeless population: those
with high needs and severe mental illness. Generalization
from the findings of this study to other homeless people
would be hazardous. However, should Housing First prove
to produce positive results in the French context, it is ar-
guable that this may well remain true for less vulnerable
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pothesis, especially in populations with moderate needs
and without mental disorders.
A further challenge for the present study will be to retain
participants at the time of follow-up. Previous longitudinal
studies on homeless individuals have managed to retain
only 60 to 85% of participants over follow-up periods of 18
to 36 months [14]. As previously explained, attempts to
improve follow-up rates in the current study will include
using food coupons, obtaining contact details of signifi-
cant others to help with locating participants and
explaining to participants the importance of conducting
follow-up.
Finally, we cannot exclude a series of limitations, such
as potential Hawthorne effects (that is, individuals from
the Housing First group may be conscious of being ob-
served or indeed benefit from being observed, which may
induce them to change their behavior for the duration of
the experiment, or indeed for longer) or John Henry ef-
fects (individuals from the Treatment-As-Usual group
may feel offended to be a comparison group and react by
altering their behavior). Contamination bias between indi-
viduals in the two groups is also a possibility, although less
likely because the number of patients included in the
present study is relatively small compared to the total
number of individuals seeking housing at each site. The
qualitative analyses used in the present study should help
us to analyze these different phenomena and take them
into account when interpreting results.
Trial status
The study started recruiting participants in August 2011,
and the recruitment is ongoing.Endnotes
aSource: http://www.emmaus-france.org.uk, 2007.
bAbsolutely homeless is defined as having had no fixed
place to stay for at least the past seven nights with little
likelihood of finding a place in the coming month.
cPrecariously housed is defined as being housed in single
room occupancy, rooming house, or hotel/motel as a pri-
mary residence AND in the past year having experienced
two or more episodes of being absolutely homeless OR
one episode of being absolutely homeless that lasted for
more than four weeks in the preceding 12 months.
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